2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole

C56H80N10O3S2Si — CID 174054477

IUPAC2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole
SMILESC[C@H]1CC[C@H](c2ccc3sc(CC4(C)CCN(C)CC4)nc3c2)N(C(=O)C(=O)Nc2cncc3cnn(COCC[Si](C)(C)C)c23)C1.C[C@H]1CC[C@H](c2ccc3sc(CC4(C)CCN(C)CC4)nc3c2)NC1
InChIInChI=1S/C35H49N7O3SSi.C21H31N3S/c1-24-7-9-29(25-8-10-30-27(17-25)38-31(46-30)18-35(2)11-13-40(3)14-12-35)41(22-24)34(44)33(43)39-28-21-36-19-26-20-37-42(32(26)28)23-45-15-16-47(4,5)6;1-15-4-6-17(22-14-15)16-5-7-19-18(12-16)23-20(25-19)13-21(2)8-10-24(3)11-9-21/h8,10,17,19-21,24,29H,7,9,11-16,18,22-23H2,1-6H3,(H,39,43);5,7,12,15,17,22H,4,6,8-11,13-14H2,1-3H3/t24-,29+;15-,17+/m00/s1
InChIKeyWYFNHDHLUMCAGG-UYIUYYKQSA-N
MW1033.54 g/mol
LogP11.20
Rot. Bonds12

About 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole

2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole (PubChem CID 174054477) has the molecular formula C56H80N10O3S2Si and a molecular weight of 1033.54 g/mol. Its IUPAC name is 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole.

Molecular Properties

Compound Name2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole
PubChem CID174054477
Molecular FormulaC56H80N10O3S2Si
Molecular Weight1033.54 g/mol
Exact Mass1032.56
IUPAC Name2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole
SMILESC[C@H]1CC[C@H](c2ccc3sc(CC4(C)CCN(C)CC4)nc3c2)N(C(=O)C(=O)Nc2cncc3cnn(COCC[Si](C)(C)C)c23)C1.C[C@H]1CC[C@H](c2ccc3sc(CC4(C)CCN(C)CC4)nc3c2)NC1
InChIInChI=1S/C35H49N7O3SSi.C21H31N3S/c1-24-7-9-29(25-8-10-30-27(17-25)38-31(46-30)18-35(2)11-13-40(3)14-12-35)41(22-24)34(44)33(43)39-28-21-36-19-26-20-37-42(32(26)28)23-45-15-16-47(4,5)6;1-15-4-6-17(22-14-15)16-5-7-19-18(12-16)23-20(25-19)13-21(2)8-10-24(3)11-9-21/h8,10,17,19-21,24,29H,7,9,11-16,18,22-23H2,1-6H3,(H,39,43);5,7,12,15,17,22H,4,6,8-11,13-14H2,1-3H3/t24-,29+;15-,17+/m00/s1
InChIKeyWYFNHDHLUMCAGG-UYIUYYKQSA-N
XLogP11.20
TPSA133.64 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds12
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001033.54
LogP ≤ 511.20
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole?
The IUPAC name of 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole (CID 174054477) is 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole.
What is the SMILES notation for 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole?
The canonical SMILES for 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole is C[C@H]1CC[C@H](c2ccc3sc(CC4(C)CCN(C)CC4)nc3c2)N(C(=O)C(=O)Nc2cncc3cnn(COCC[Si](C)(C)C)c23)C1.C[C@H]1CC[C@H](c2ccc3sc(CC4(C)CCN(C)CC4)nc3c2)NC1.
What is the InChIKey of 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole?
The InChIKey is WYFNHDHLUMCAGG-UYIUYYKQSA-N. The full InChI is InChI=1S/C35H49N7O3SSi.C21H31N3S/c1-24-7-9-29(25-8-10-30-27(17-25)38-31(46-30)18-35(2)11-13-40(3)14-12-35)41(22-24)34(44)33(43)39-28-21-36-19-26-20-37-42(32(26)28)23-45-15-16-47(4,5)6;1-15-4-6-17(22-14-15)16-5-7-19-18(12-16)23-20(25-19)13-21(2)8-10-24(3)11-9-21/h8,10,17,19-21,24,29H,7,9,11-16,18,22-23H2,1-6H3,(H,39,43);5,7,12,15,17,22H,4,6,8-11,13-14H2,1-3H3/t24-,29+;15-,17+/m00/s1.
What are the key properties of 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole?
2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole has a molecular weight of 1033.54 g/mol, XLogP of 11.20, 12 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2R,5S)-2-[2-[(1,4-dimethylpiperidin-4-yl)methyl]-1,3-benzothiazol-5-yl]-5-methylpiperidin-1-yl]-2-oxo-N-[1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]pyridin-7-yl]acetamide;2-[(1,4-dimethylpiperidin-4-yl)methyl]-5-[(2R,5S)-5-methylpiperidin-2-yl]-1,3-benzothiazole is sourced from PubChem (CID 174054477), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).